Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 325-332 , April 2006

Effects of anpirtoline on regional serotonin synthesis in the rat brain: an autoradiographic study

  • Arata Watanabe

      Affiliations

    • Permanent address: Department of Neurosurgery, University of Yamanashi, 1110 Shimokato Tamaho-cho, Nakakoma-gun, Yamanashi 409-3898, Japan.
    • ,
  • Akio Nakai

      Affiliations

    • Permanent address: Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
    • ,
  • Yoshihiro Tohyama

      Affiliations

    • Permanent address: Department of Neurosurgery, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
    • ,
  • Khnah Q. Nguyen
    • ,
  • Mirko Diksic

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 514 398 8526; fax: +1 514 398 8195.

Received 22 June 2005 ,Revised 9 August 2005 ,Accepted 9 August 2005.

References 

  1. van Praag HM. Anxiety and aggression as pacemakers of depression: a dimensional variation of the serotonin hypothesis of depression. In:  Mendlewicz J,  Racagni G,  Brunello N editor. Current therapeutic approaches to panic and other anxiety disorders. Basel: Karger; 1994;p. 144–150
  2. Heninger GH. Indoleamine: the role of serotonin in clinical disorders. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995;p. 471–482
  3. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann NY Acad Sci. 1998;861:204–216
  4. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacology. 1994;33:275–317
  5. Göthert M, Hamon M, Barann M, Bonisch H, Gozlan H, Laguzzi R, et al. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist. Br J Pharmacol. 1995;114:269–274
  6. Palacios JM, Waeber C, Hoyer D, Mengod G. Distribution of serotonin receptors. Ann NY Acad Sci. 1991;600:36–51
  7. Pineyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev. 1999;51:533–591
  8. Invernizzi R, Carli M, Di Clemente A, Samanin R. Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J Neurochem. 1991;56:243–247
  9. Hjorth S, Tao R. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur J Pharmacol. 1991;209:249–252
  10. Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedebergs Arch Pharmacol. 1986;332:1–7
  11. Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, et al. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br J Pharmacol. 1992;105:732–738
  12. Metzenauer P, Barnes NM, Costall B, Gozlan H, Hamon M, Kelly ME, et al. Anxiolytic-like actions of anpirtoline in a mouse light–dark aversion paradigm. NeuroReport. 1992;3:527–529
  13. Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, et al. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry. 2003;8:994–1007
  14. Nakai A, Diksic M, Kumakura Y, D'Souza D, Kersey K. The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2005;17:212–221
  15. Hummel T, Hummel C, Friedel I, Pauli E, Kobal G. A comparison of the antinociceptive effects of imipramine, tramadol and anpirtoline. Br J Clin Pharmacol. 1994;37:325–333
  16. Hillegaart V, Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol. 1998;125:1733–1743
  17. Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol Psychiatry. 2001;49:557–568
  18. O'Neill MF, Conway MW. Role of 5-HT(1A) and 5-HT(1B) receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology. 2001;24:391–398
  19. de Almeida RM, Miczek KA. Aggression escalated by social instigation or by discontinuation of reinforcement (“frustration”) in mice: inhibition by anpirtoline: a 5-HT1B receptor agonist. Neuropsychopharmacology. 2002;27:171–181
  20. O'Neill MF, Parameswaran T. RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors. Psychopharmacology (Berl). 1997;132:255–260
  21. Hjorth S, Suchowski CS, Galloway MP. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse. 1995;19:170–176
  22. Tohyama Y, Yamane F, Fikre Merid M, Blier P, Diksic M. Effects of serotonin receptors agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J Neurochem. 2002;80:788–798
  23. Hasegawa S, Watanabe A, Nishi K, Nguyen KQ, Diksic M. Selective 5-HT1B receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study. Neurochem Int. 2005;46:261–272
  24. Adell A, Celada P, Artigas F. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem. 2001;79:172–182
  25. Okazawa H, Yamane F, Blier P, Diksic M. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem. 1999;72:2022–2031
  26. Tohyama Y, Yamane F, Merid MF, Diksic M. Effects of selective 5-HT1A receptor antagonists on regional serotonin synthesis in the rat brain: an autoradiographic study with alpha- [14C]methyl-l-tryptophan. Eur Neuropsychopharm. 2001;11:193–202
  27. Sleight AJ, Smith RJ, Marsden CA, Palfreyman MG. The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo. Neuropharmacology. 1989;28:477–480
  28. Auerbach SB, Rutter JJ, Juliano PJ. Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis. Neuropharmacology. 1991;30:307–311
  29. Martin KF, Hannon S, Phillips I, Heal DJ. Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo. Br J Pharmacol. 1992;106:139–142
  30. Bosker FJ, van Esseveldt KE, Klompmakers AA, Westenberg HG. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berl). 1995;117:358–363
  31. Rilke O, Will K, Jahkel M, Oehler J. Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1125–1144
  32. Bruinvels AT, Landwehrmeyer B, Gustafson EL, Durkin MM, Mengod G, Branchek TA, et al. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 1994;33:367–386
  33. O'Neill MF, Fernández AG, Palacios JM. Activation of central 5HT1B receptors increases locomotor activity in mice. Hum Psychopharmacol: Clin Exp. 1997;12:431–435
  34. Nelson N. Presynaptic events involved in neurotransmission. J Physiol (Paris). 1993;87:171–178
  35. Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL. A new method to measure brain serotonin synthesis in vivo: I. Theory and basic data for a biological model. J Cereb Blood Flow Metab. 1990;10:1–12
  36. Vanier M, Tsuiki K, Grdisa M, Worsley K, Diksic M. Determination of the lumped constant for the alpha-methyltryptophan method of estimating the rate of serotonin synthesis. J Neurochem. 1995;64:624–635
  37. Mück-Šeler D, Diksic M. The acute effects of reserpine and NSD-1015 on the brain serotonin synthesis rate measured by an autoradiographic method. Neuropsychopharmacology. 1995;12:251–262
  38. Swedberg MD, Shannon HE, Nickel B, Goldberg SR. D-16949 (anpirtoline): a novel serotonergic (1-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat. J Pharmacol Exp Ther. 1992;263:1015–1022
  39. Wirtshafter D, Cook DF. Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. NeuroReport. 1998;9:1217–1221
  40. Nagahiro S, Takada A, Diksic M, Sourkes TL, Missala K, Yamamoto YL. A new method to measure brain serotonin synthesis in vivo: II. A practical autoradiographic method tested in normal and lithium-treated rats. J Cereb Blood Flow Metab. 1990;10:13–21
  41. Mück-Šeler D, Jevric-Causevic A, Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem. 1996;67:2434–2442
  42. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986;
  43. Takada A, Grdisa M, Diksic M, Gjedde A, Yamamoto YL. Rapid steady-state analysis of brain blood–brain transfer of l-Trp in rat, with special reference to the plasma protein binding. Neurochem Int. 1993;23:351–359
  44. Diksic M, Nagahiro S, Grdisa M. The regional rate of serotonin synthesis estimated by the alpha-methyl-l-tryptophan method in rat brain from single time point. J Cereb Blood Flow Metab. 1995;15:806–813
  45. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statis. 1979;6:65–70
  46. Tabachnick BG, Fidell LS. In: Using multivariate statistics. 3rd Ed. New York (NY): Harper Collins College Publishers; 1996;p. 402–403
  47. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev. 1993;18:1–32
  48. Macor JE, Burkhart CA, Heym JH, Ives JL, Lebel LA, Newman ME, et al. 3-(1,2,5,6-Tetrahydropyrid-4-yl) pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J Med Chem. 1990;33:2087–2093
  49. Davidson C, Stamford JA. The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT1B/D receptor antagonists. Neurosci Lett. 1995;188:41–44
  50. Verge D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H, et al Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci. 1986;6:3474–3482
  51. Pazos A, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors. Brain Res. 1985;346:205–230
  52. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol. 2000;14:177–185
  53. Yamane F, Tohyama Y, Diksic M. Acute and chronic d-fenfluramine treatments have different effects on serotonin synthesis rates in the rat brain: an autoradiographic study. Neurochem Res. 1999;24:1611–1620
  54. Dilts RP, Boadle-Biber MC. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci Lett. 1995;199:78–80
  55. Daugherty WP, Corley KC, Phan T-H, Boadle-Biber MC. Further studies on the activation of rat median raphe serotonergic neurons by inescapable sound stress. Brain Res. 2001;923:103–111

PII: S0969-8051(05)00203-9

doi: 10.1016/j.nucmedbio.2005.08.002

Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 325-332 , April 2006

Article Tools

* Image Usage & Resolution